Sensus Healthcare (SRTS) Cash & Equivalents (2015 - 2026)

Sensus Healthcare has reported Cash & Equivalents for 12 years, with the latest figure at $15.2 million in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 31.48% year-over-year to $15.2 million in Q2 2026; TTM through Jun 2026 was $15.2 million, a 31.48% decrease from a year earlier, with the FY2025 full-year figure at $22.1 million, changed 0.12% from the prior year.
• Cash & Equivalents was $15.2 million for Q2 2026 at Sensus Healthcare, down from $18.3 million in the prior quarter.
• The five-year high for Cash & Equivalents was $37.6 million in Q3 2022, with the low at $14.7 million in Q1 2024.
• Average Cash & Equivalents over 5 years is $22.9 million, with a median of $22.1 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents soared 140.48% in 2022, then slumped 45.48% in 2023.
• Over 5 years, Cash & Equivalents stood at $25.5 million in 2022, then fell by 9.29% to $23.1 million in 2023, then slipped by 4.72% to $22.1 million in 2024, then gained by 0.12% to $22.1 million in 2025, then plunged by 31.23% to $15.2 million in 2026.
• The last three Cash & Equivalents figures came in at $15.2 million (Q2 2026), $18.3 million (Q1 2026), and $22.1 million (Q4 2025), per Business Quant data.